Provectus Biopharmaceuticals (PVCT) Non Operating Interest Expenses (2018 - 2026)
Provectus Biopharmaceuticals (PVCT) reported Non Operating Interest Expenses of $50,319 for Q2 2026, down 2.0% from $51,353 a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Non Operating Interest Expenses (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Provectus Biopharmaceuticals' Non Operating Interest Expenses came in at $121,287, down 76.8% year-over-year; for FY2021, it was $961,702, down 45.0% from FY2020.
- Non Operating Interest Expenses has a three-year compound annual growth rate of -0.3% (FY2018 to FY2021).
- By year, Non Operating Interest Expenses came in at $1.75 million in FY2020 (+20.1%), $1.46 million in FY2019 (+50.1%) and $969,715 in FY2018.
- The Q2 2026 figure ranks as the lowest quarterly Non Operating Interest Expenses since Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Provectus Biopharmaceuticals | 19.16 Mn | 17.27 Mn | - | 50,319.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50,319.00 |
| Jun 30, 2025 | 51,353.00 |
| Dec 31, 2021 | 16,093.00 |
| Sep 30, 2021 | 3,522.00 |
| Jun 30, 2021 | 452,812.00 |
| Mar 31, 2021 | 489,275.00 |
| Dec 31, 2020 | 469,175.00 |
| Sep 30, 2020 | 463,390.00 |
| Jun 30, 2020 | 410,404.00 |
| Mar 31, 2020 | 405,151.00 |
| Dec 31, 2019 | 386,484.00 |
| Sep 30, 2019 | 377,576.00 |
| Jun 30, 2019 | 356,451.00 |
| Mar 31, 2019 | 334,573.00 |
| Dec 31, 2018 | 272,501.00 |
| Sep 30, 2018 | 256,173.00 |
| Jun 30, 2018 | 234,473.00 |
API Access
Provectus Biopharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();